1. Home
  2. MXCT

MXCT

MaxCyte Inc.

Logo MaxCyte Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-22-2024 12:32pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Founded: 1999 Country:
United States
United States
Employees: 143 City: ROCKVILLE
Market Cap: 411.3M IPO Year: 2021
Target Price: $8.67 AVG Volume (30 days): 592.4K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.37 EPS Growth: N/A
52 Week Low/High: $2.45 - $5.54 Next Earning Date: 05-07-2024
Revenue: $41,288,000 Revenue Growth: -6.72%
Revenue Growth (this year): -15.46% Revenue Growth (next year): 33.01%

Share on Social Networks:

Stock Insider Trading Activity of MaxCyte Inc. (MXCT)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Johnston John Joseph MXCT Director Nov 27 '23 Sell $4.59 5,000 $22,950.00 120,583 SEC Form 4